Covalon Technologies (CVE:COV) Stock Price Down 0.5% – Here’s What Happened

Covalon Technologies Ltd. (CVE:COV)’s stock price fell 0.5% during trading on Tuesday . The stock traded as low as C$2.06 and last traded at C$2.15. 60,605 shares changed hands during mid-day trading, an increase of 391% from the average session volume of 12,342 shares. The stock had previously closed at C$2.16.

Covalon Technologies Stock Down 1.8%

The company has a quick ratio of 6.45, a current ratio of 7.57 and a debt-to-equity ratio of 6.33. The firm has a fifty day moving average of C$1.99 and a 200 day moving average of C$1.84. The stock has a market cap of C$59.10 million, a PE ratio of 42.80 and a beta of 1.14.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.